Mechanistic Effects of IVIg in Neuroinflammatory Diseases: Conclusions Based on Clinicopathologic Correlations

Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome

(2013) Marinos C. Dalakas   EXPERIMENTAL NEUROLOGY

Immunology of stiff person syndrome and other GAD-associated neurological disorders

(2013) Harry Alexopoulos et al.   Expert Review of Clinical Immunology

Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives

(2013) Jens Schmidt et al.   Expert Review of Clinical Immunology

Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: Quantitative assessment of inflammation and β-amyloid in the muscle

(2012) Jana Zschüntzsch et al.   ARTHRITIS AND RHEUMATISM

Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death

(2012) Jens Schmidt et al.   BRAIN

Pathogenic Considerations in Sporadic Inclusion-Body Myositis, a Degenerative Muscle Disease Associated With Aging and Abnormalities of Myoproteostasis

(2012) Valerie Askanas et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Recovery of the T-cell repertoire in CIDP by IV immunoglobulins

(2012) A. K. Mausberg et al.   NEUROLOGY

Expression and function of the inhibitory Fcγ-receptor in CIDP

(2011) Falk Nimmerjahn et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy

(2010) N. Yuki et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of  B-crystallin is associated with amyloid precursor protein and accumulation of  -amyloid

(2009) I E Muth et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Interplay between inflammation and degeneration: Using inclusion body myositis to study “neuroinflammation”

(2008) Marinos C. Dalakas   ANNALS OF NEUROLOGY

A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis

(2008) Sara Fuchs et al.   JOURNAL OF NEUROIMMUNOLOGY